New Directions in Chemotherapy-Induced Neutropenia

home / insights / chemotherapy-induced-neutropenia

A clinician and payer discuss the impact of chemotherapy-induced neutropenia on patients as well as the healthcare system, and discuss the latest in prophylactic treatment, especially during the COVID-19 pandemic.

© 2023 MJH Life Sciences
AJMC®
All rights reserved.